Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy that is characterized by a slowly progressive sensory and motor involvement lasting at least 2 months. We present a CIDP patient on subcutaneous Ig (SCIg). Upon fine-tuning his dose from 24 to 28 g/week, this showed a dramatic improvement in both hand grip (13–25%) and dorsiflexion (73–278%). Follow-up nerve conduction studies also demonstrated significant improvements in latencies, motor amplitudes, and conduction velocities. Ongoing surveillance of CIDP patients receiving SCIg therapy is therefore necessary to ensure therapeutic optimization.
https://www.researchpad.co/tools/openurl?pubtype=article&doi=10.1159/000505320&title=Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy&author=&keyword=Chronic inflammatory demyelinating polyradiculoneuropathy,Demyelinating polyneuropathy,Subcutaneous Ig,IVIG,Inflammatory polyneuropathy,&subject=Single Case − General Neurology,
Thank you for registering to the ResearchPad web
application. The link has been sent to your registered email id to
verify your email account. Please follow the email to complete
verification process before downloading the eBooks.